ARCHIVES

Rosenberg’s Latest Results: 22% Response Seen With LAK/IL-2, 13% With High Dose IL-2 Alone

This article is from The Cancer Letter archive.

Vol. 13 No. 15 | April 10, 1987

Download PDF Visit The Full Archive

Related Articles

Roche Markets CMV Test in Europe

April 29, 2011

Potti Claimed Rhodes Credential in Bio Submitted for DOD Funding

July 30, 2010

In Brief: Esparza, Young, Busch, Rush Head Oncology Societies; Hipple Centers Honors Harry Eagle

June 2, 1989

In Brief: White House Names Five To NCAB; Carson Chairs Nursing Foundation; NF Research Award

October 9, 1992

NCAB To Monitor Virus Program; NCI Answers Zinder Report Criticisms

June 28, 1974

FY 1990 Bypass Budget f $2.345 Billion Approved By NCAB; Hammer’s Effort Makes That Possible

May 20, 1988